The Coronavirus Disease 2019 (COVID-19) pandemic has been ongoing for over 3 years, during which numerous clinical and experimental studies have been conducted. The objective of this systematic review and meta-analysis was to assess the survival probability and complications of COVID-19 patients receiving extracorporeal membrane oxygenation (ECMO).
Methods
We searched the databases by using Population-Intervention-Comparison-Outcome-Study Design (PICOS). We conducted a search of the PubMed, Web of Science, and EMBASE databases to retrieve studies published until December 10, 2022. A random-effects meta-analysis, subgroup analysis, and assessed the studies using the Newcastle-Ottawa Scale score. The results were presented as pooled morbidity with 95% confidence intervals.
Results
The study was conducted on 19 studies that enrolled a total of 1494 patients, and the results showed a pooled survival probability of 66.0%. The pooled morbidity for intracranial hemorrhage was 8.7%, intracranial thrombosis 7.0%, pneumothorax 9.0%, pulmonary embolism 11.0%, pulmonary hemorrhage 9.0%, heart failure 14.0%, liver failure 13.0%, renal injury 44.0%, gastrointestinal hemorrhage 6.0%, gastrointestinal ischemia 6.0% and venous thrombosis 31.0%.
Conclusion
This systematic review and meta-analysis of observational studies focused on the survival probability and complications of COVID-19 patients undergoing ECMO, which are significant in evaluating the use of ECMO in COVID-19 patients and provide a basis for further research.
Trial registration
Our study was registered on PROSPERO with registration number CRD42022382555.
KatoFBunyaNNakayamaR, et al.Multisystem inflammatory syndrome in adults with COVID-19 requiring mechanical ventilation: a retrospective cohort study. Acute Med Surg2023; 10: e885.
2.
JacobsJPStammersAHLouisSJD, et al.Variation in survival in patients with Coronavirus Disease 2019 supported with extracorporeal membrane oxygenation: a multi-institutional analysis of 594 consecutive patients with Coronavirus Disease 2019 supported with extracorporeal membrane oxygenation at 49 hospitals within 21 states. J Thorac Cardiovasc Surg2023; 165: 1837–1848.
HongXXiongJFengZ, et al.Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?Int J Infect Dis2020; 94: 78–80.
5.
ShekarKBadulakJPeekG, et al.Extracorporeal Life support organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers. Am Soc Artif Intern Organs J2020; 66(7): 707–721.
6.
EvansLRhodesAAlhazzaniW, et al.Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med2021; 47(11): 1181–1247.
7.
NoahMAPeekGJFinneySJ, et al.Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA2011; 306(15): 1659–1668.
8.
BarbaroRPMacLarenGBoonstraPS, et al.Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry [published correction appears in Lancet. Lancet. 2020;396(10257):1071–1078.
KonZNSmithDEChangSH, et al.Extracorporeal membrane oxygenation support in severe COVID-19. Ann Thorac Surg2021; 111(2): 537–543.
11.
MoherDShamseerLClarkeM, et al.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev2015; 4(1): 1.
12.
JiangSLZhanYJYanP, et al.Pulse oximetry and perfusion index screening for congenital heart defects: a systematic review and meta-analysis. Am J Perinatol2023; 40(15): 1611–1617.
13.
YueYLiWTangJ, et al.Maternal intake of caffeinated products and birth defects: a systematic review and meta-analysis of observational studies. Crit Rev Food Sci Nutr2021; 61(22): 3756–3770.
14.
ChenBBenedettiA. Quantifying heterogeneity in individual participant data meta-analysis with binary outcomes. Syst Rev2017; 6(1): 243.
15.
HajageDCombesAGuervillyC, et al.Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: an emulated target trial analysis. Am J Respir Crit Care Med2022; 206(3): 281–294.
16.
DreierEMalfertheinerMVDienemannT, et al.ECMO in COVID-19-prolonged therapy needed? A retrospective analysis of outcome and prognostic factors. Perfusion2021; 36(6): 582–591.
17.
SchmidtMLangouetEHajageD, et al.Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris. Crit Care2021; 25(1): 355.
18.
NesselerNFadelGMansourA, et al.Extracorporeal membrane oxygenation for respiratory failure related to COVID-19: a nationwide cohort study. Anesthesiology2022; 136(5): 732–748.
19.
RaasveldSJDelnoijTSRBromanLM, et al.Extracorporeal membrane oxygenation in patients with COVID-19: an international multicenter cohort study. J Intensive Care Med2021; 36(8): 910–917.
20.
KüçükAOKüçükMPAyçiçekO, et al.Extracorporeal membrane oxygenation experiences during COVID-19 pandemic, third wave with younger patients: a retrospective observational study. Turk J Emerg Med2022; 22(1): 36–43.
21.
GeorgeTJSheasbyJShihE, et al.Intermediate-term survival and functional outcomes of COVID-19 extracorporeal membrane oxygenation patients. J Card Surg2022; 37(4): 789–794.
22.
SmithDEChangSHGeraciTC, et al.One-year outcomes with venovenous extracorporeal membrane oxygenation support for severe COVID-19. Ann Thorac Surg2022; 114(1): 70–75.
23.
GribenskASchneiderAGallaherJR, et al.Posthospitalization outcomes after extracorporeal membrane oxygenation (ECMO) for COVID-19. Surgery2022; 172(1): 466–469.
24.
AlhumaidSAl MutairAAlghazalHA, et al.Extracorporeal membrane oxygenation support for SARS-CoV-2: a multi-centered, prospective, observational study in critically ill 92 patients in Saudi Arabia. Eur J Med Res2021; 26(1): 141.
25.
HarounMWPatelSRSimsDB, et al.Characteristics and outcomes of COVID-19 patients supported by venoarterial or veno-arterial-venous extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth2022; 36(8 Pt B): 2935–2941.
26.
KotarskiVSantiniMKrajinovićV, et al.Extracorporeal membrane oxygenation for the treatment of ARDS in Covid-19 and influenza patients: does etiology matter?Int J Artif Organs2022; 45(7): 647–651.
27.
ParzyGDavietFPuechB, et al.Venous thromboembolism events following venovenous extracorporeal membrane oxygenation for severe acute respiratory syndrome coronavirus 2 based on CT scans. Crit Care Med2020; 48(10): e971–e975.
28.
ShihEDiMaioJMSquiersJJ, et al.Venovenous extracorporeal membrane oxygenation for patients with refractory coronavirus disease 2019 (COVID-19): multicenter experience of referral hospitals in a large health care system. J Thorac Cardiovasc Surg2022; 163(3): 1071–1079.e3.
29.
BergmanZRWotheJKAlwanFS, et al.Risk factors of mortality for patients receiving venovenous extracorporeal membrane oxygenation for COVID-19 acute respiratory distress syndrome. Surg Infect2021; 22(10): 1086–1092.
30.
MustafaAKJoshiDJAlexanderPJ, et al.Comparative propensity matched outcomes in severe COVID-19 respiratory failure-extracorporeal membrane oxygenation or maximum ventilation alone. Ann Surg2021; 274(5): e388–e394.
31.
BermeaRSRazYSerticF, et al.Increased intracranial hemorrhage amid elevated inflammatory markers in those with COVID-19 supported with extracorporeal membrane oxygenation. Shock2021; 56(2): 206–214.
32.
BlazoskiCBaramMHiroseH. Outcomes of extracorporeal membrane oxygenation in acute respiratory distress syndrome due to COVID-19: the lessons learned from the first wave of COVID-19. J Card Surg2021; 36(7): 2219–2224.
33.
SakaiTHoshinoCNakanoM, et al.Rehabilitation characteristics of acute-stage COVID-19 survivors managed with extracorporeal membrane oxygenation in the intensive care unit. Prog Rehabil Med2022; 7: 20220015.
34.
NatanovRKunkelERWiesnerO, et al.Determinants of survival in patients on extracorporeal membrane oxygenation therapy due to severe covid-19. Perfusion2023; 38(7): 1393–1398.
35.
TabatabaiAGhneimMHKaczorowskiDJ, et al.Mortality risk assessment in COVID-19 venovenous extracorporeal membrane oxygenation. Ann Thorac Surg2021; 112(6): 1983–1989.
36.
ChongWHSahaBKMedarovBI. Clinical characteristics between survivors and nonsurvivors of COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO) support: a systematic review and meta-analysis. J Intensive Care Med2022; 37(3): 304–318.
37.
ChongWHSahaBKMedarovBI. A systematic review and meta-analysis comparing the clinical characteristics and outcomes of COVID-19 and influenza patients on ECMO. Respir Investig2021; 59(6): 748–756.
38.
CharltonMDasheySStubbsA, et al.Comparing SARS-CoV-2 and influenza A(H1N1)pdm09-infected patients requiring ECMO - a single-centre, retrospective observational cohort experience. J Infect2021; 82(4): 84–123.
39.
LiXHuMZhengR, et al.Delayed initiation of ECMO is associated with poor outcomes in patients with severe COVID-19: a multicenter retrospective cohort study. Front Med2021; 8: 716086.
40.
ZhuYZhangMZhangR, et al.Extracorporeal membrane oxygenation versus mechanical ventilation alone in adults with severe acute respiratory distress syndrome: a systematic review and meta-analysis. Int J Clin Pract2021; 75(9): e14046.
41.
HaiducAAAlomSMelamedN, et al.Role of extracorporeal membrane oxygenation in COVID-19: a systematic review. J Card Surg2020; 35(10): 2679–2687.
42.
HuangSZhaoSLuoH, et al.The role of extracorporeal membrane oxygenation in critically ill patients with COVID-19: a narrative review. BMC Pulm Med2021; 21(1): 116.
43.
RamanathanKShekarKLingRR, et al.Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis [published correction appears in Crit Care. Crit Care. 2021;25(1):211.
44.
PavoneNBurzottaFMassettiM. Extracorporeal membrane oxygenation for COVID-19: effective weapon or futile effort?Minerva Cardioangiol2020; 68(5): 365–367.
45.
HelmsJTacquardCSeveracF, et al.High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med2020; 46(6): 1089–1098.
46.
ZuoYZuoMYalavarthiS, et al.Neutrophil extracellular traps and thrombosis in COVID-19. J Thromb Thrombolysis2021; 51(2): 446–453.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
